Inactivated whole-virus antigen (WIV)

An inactivated whole-virus antigen is a vaccine component consisting of entire viral particles that have been rendered non-infectious through chemical or physical means, such as treatment with formaldehyde or heat [1][3]. Unlike subunit vaccines that utilize only specific fragments of a pathogen, whole-virus antigens present the complete structural repertoire of the virus to the host immune system, potentially eliciting a broader range of neutralizing antibodies and T-cell responses [2][4]. These antigens do not possess a specific molecular host target in the traditional pharmacological sense; instead, they serve as the immunogenic stimulus recognized and processed by the host's innate and adaptive immune systems [3]. Upon administration, the inactivated virus is typically internalized by professional antigen-presenting cells, such as dendritic cells, which then present viral peptides to T-lymphocytes to initiate protective immune memory [4]. This platform is a cornerstone of vaccinology, used effectively for decades to prevent diseases such as polio, hepatitis A, and rabies [1][2]. Because the virus is inactivated, it cannot replicate or cause disease in the recipient, making it a safer alternative to live-attenuated vaccines for immunocompromised individuals [3].

Other names

Whole inactivated virusKilled virus antigenInactivated viral particleWhole-cell antigen

Induction of active immunity through the presentation of multiple viral epitopes to the host immune system, primarily via the exogenous pathway involving MHC class II molecules on antigen-presenting cells [3][4].